Laryngeal myxomas, although benign in nature, represent a diagnostic challenge due to their infrequent occurrence and the commonality of their symptoms with more routine laryngeal pathologies, such as polyps or nodules. Predominantly affecting the mandible and maxilla within the head and neck region, the occurrence of myxomas in the larynx is notably rare thus making each case a valuable addition to the medical literature.1 Myxomas are characterized by their mesenchymal origin, with a histological hallmark being the production of an abundant extracellular myxoid matrix. This matrix is composed of undifferentiated stellate cells, embedded within a loose mucoid stroma, distinguishing them from other laryngeal lesions on microscopic level. Clinically, patients with laryngeal myxomas may present with symptoms ranging from hoarseness to less commonly airway obstruction, mimicking the presentation of more frequently encountered laryngeal conditions.2